Meyka AI API is live for developers.Start building.
Advertisement
Rite Aid Corporation

Rite Aid Corporation (RAD) Stock Overview

Explore Rite Aid Corporation’s financial performance, market position, analyst ratings, and future outlook.

RADNYSE
HealthcareMedical - Pharmaceuticals
$0.65
$0.13(16.81%)
U.S. Market opens in 43h 13m
Advertisement

Rite Aid Corporation (RAD)

Meyka AI Score

Z

Key Financials

Market Cap36.8M
P/E Ratio-0.05
EPS (TTM)$-14.34
ROE2.76%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$0.00

RAD Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Rite Aid Corporation (RAD) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.05 and a market capitalization of 36.8M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
170.13%
1-Month Change
-16.81%
3-Month Change
-71.94%
6-Month Change
-65.15%
Year-to-Date (YTD) Change
-80.59%
1-Year Change
-89.03%
3-Year Change
-94.44%
5-Year Change
-97.51%
All-Time (Max) Change
-97.62%

Contact Information

17177612633
1200 Intrepid Avenue, Philadelphia, PA, NaN

Company Facts

470,000 Employees
IPO DateMar 17, 1980
CountryUS

Frequently Asked Questions